(lp0
S"Tetraphase Pharmaceuticals Inc Is Climbing Again Today -- Here's Why Motley Fool - Mar 10, 2017 Shares of Tetraphase Pharmaceuticals Inc , a clinical-stage biotech developing antibiotics, continued its impressive climb with another gain of about 15.8%, as of 11:46 a.m."
p1
aS'Tetraphase Pharmaceuticals Inc.  Plunges 5.02% on March 21 Equities.com - Mar 21, 2017 Tetraphase Pharmaceuticals Inc.  had a rough trading day for Tuesday March 21 as shares tumbled 5.02%, or a loss of $-0.42 per share, to close at $7.95.'
p2
aS'Tetraphase Pharmaceuticals to Present at the 29th Annual ROTH Conference GlobeNewswire  - Mar 6, 2017 WATERTOWN, Mass., March 06, 2017  -- Tetraphase Pharmaceuticals, Inc.  a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant  infections, today&nbsp;...'
p3
aS'Buy or Sell? Average Brokerage Ratings on Tetraphase Pharmaceuticals, Inc ... StockNewsJournal - 20 hours ago ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.Tetraphase Pharmaceuticals, Inc. , Planet Fitness, Inc.  Stock ... - The USA CommerceWELLINGTON MANAGEMENT GROUP LLP is the biggest holder of Tetraphase ... - Post Analyst'
p4
aS'Tetraphase Pharmaceuticals to Host Conference Call on March 8 to Discuss ... GlobeNewswire  - Mar 3, 2017 WATERTOWN, Mass., March 03, 2017  -- Tetraphase Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant  infections, today&nbsp;...Tetraphase Pharmaceuticals Inc.  Breaks into New 52-Week High on March ... - Equities.com'
p5
aS"Tetraphase Pharmaceuticals, Ionis Pharmaceuticals, Facebook Stocks Moving Today Schaeffers Research  - Mar 10, 2017 The S&amp;P is set to snap a six-week winning streak, with traders turning their attention to next week's Fed decision after a blowout jobs report."
p6
aS'Tetraphase Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 17 Equities.com - Mar 17, 2017 Tetraphase Pharmaceuticals Inc.  traded on unusually high volume on Mar. 17, as the stock gained 5.21% to close at $8.28.Tetraphase Pharmaceuticals Inc  Cut to Sell at Zacks Investment Research - BNB Daily The Tetraphase Pharmaceuticals Inc  Director Buys $82390.00 in Stock - Petro Global News 24'
p7
aS'Analyst Activity  Stifel Nicolaus Raises Its Price Target On Tetraphase ... Market Exclusive - Mar 9, 2017 Tetraphase Pharmaceuticals, Inc.  is a clinical-stage biopharmaceutical company. The Company uses its chemistry technology to create antibiotics for multidrug-resistant infections.'
p8
aS'Tetraphase Pharmaceuticals Inc.  Soars 14.31% on March 10 Equities.com - Mar 10, 2017 Tetraphase Pharmaceuticals Inc.  had a good day on the market for Friday March 10 as shares jumped 14.31% to close at $6.95.'
p9
aS'Hynes Keller &amp; Hernandez, LLC Announces Investigation of Tetraphase ... PR Newswire  - Jun 23, 2016 NEW YORK, June 23, 2016 /PRNewswire/ -- Hynes Keller &amp; Hernandez, LLC is investigating potential claims against the Board of Directors of Tetraphase Pharmaceuticals Inc.   concerning possible breaches&nbsp;...'
p10
a.